Clinical Trials Browser

Phase 2/3 × Unknown × lenvatinib × Clear all

NCT05250843 2023-10-13

TACE/HAIC Combined With Lenvatinib and Sintilimab in Neoadjuvant Therapy for Intermediate-stage HCC

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT05322187 2022-04-11

sPLENTY-pc

Phase 2/3 Unknown

Gastrointestinal

Liver Neoplasms, Neoplasms, Hepatoblastoma

NCT04319484 2020-03-24

LLTHVV

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular

NCT04168944 2019-11-19

Lenvatinib Following Liver Transplantation in Patients With High-Risk Hepatocellular Carcinoma

Phase 2/3 Unknown

Gastrointestinal

Carcinoma, Hepatocellular